Identification of the major SHPTP2-binding protein that is tyrosine-phosphorylated in response to insulin

K Yamauchi1, V Ribon, A R Saltiel

  • 1Department of Physiology and Biophysics, University of Iowa, Iowa City 52242, USA.

Insights

Insulin signaling involves a tyrosine-phosphorylated 115-kDa protein (pp115) binding to SHPTP2 phosphatase. This interaction is enhanced when SHPTP2 is catalytically inactive, suggesting pp115 is a key substrate.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Molecular Signaling

Background:

  • SHPTP2 (Src homology 2 domain-containing protein-tyrosine phosphatase 2) is a key regulator in cellular signaling pathways.
  • Insulin receptor signaling is crucial for glucose homeostasis and metabolic regulation.
  • Tyrosine phosphorylation plays a critical role in mediating signal transduction.

Purpose of the Study:

  • To identify and characterize proteins that associate with SHPTP2 in response to insulin stimulation.
  • To investigate the role of SHPTP2 in insulin signaling and identify its potential substrates.
  • To determine if pp115 is a direct substrate of SHPTP2.

Main Methods:

  • Immunoprecipitation of SHPTP2 from insulin-stimulated cells (3T3L1 adipocytes and CHO cells expressing human insulin receptor).
  • Coimmunoprecipitation to identify associated proteins, followed by SDS-PAGE and Western blotting.
  • Expression of wild-type and catalytically inactive Myc-tagged SHPTP2 mutants to assess functional interactions.

Main Results:

  • Insulin stimulation led to the coimmunoprecipitation of a tyrosine-phosphorylated 115-kDa protein (pp115) with SHPTP2.
  • Platelet-derived growth factor stimulation did not significantly increase pp115 coimmunoprecipitation with SHPTP2, indicating specificity.
  • Association of SHPTP2 with insulin receptor substrate-1 was minimal (<2%).
  • Expression of a catalytically inactive SHPTP2 mutant significantly enhanced pp115 coimmunoprecipitation compared to wild-type SHPTP2.

Conclusions:

  • The insulin-stimulated tyrosine-phosphorylated 115-kDa protein (pp115) is the predominant in vivo SHPTP2-binding protein.
  • pp115 is likely a physiological substrate for the SHPTP2 protein-tyrosine phosphatase.
  • These findings elucidate a novel interaction in insulin signaling, highlighting pp115 as a potential target for SHPTP2 activity.

Related Concept Videos

Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...